ArticleScientific reports2026
Long-term respiratory stability of elderly patients recovering from acute respiratory failure and invasive mechanical ventilation: a retrospective cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Long-term outcomes after discharge remain a challenge in critically ill elderly patients. We aimed to evaluate the long-term survival without repeat mechanical ventilation (MV) in elderly survivors of acute respiratory failure (ARF). We retrospectively included 1533 elderly patients aged 65 years or older who were admitted with ARF and invasive MV, successfully recovered, were liberated from MV, and were discharged between January 2010 and December 2019. Patients who were MV-dependent at discharge or died in the hospital were excluded. The primary outcome was survival without repeat MV. Secondary outcomes were factors associated with survival without repeat MV. Among enrolled patients, 524 patients were aged 65–74 years, 613 were aged 75–84 years, and 396 were aged 85 years or older. Kaplan–Meier analysis revealed that the overall 1-year survival rate without repeat MV was 73%. Pneumonia, MV ≥ 21 days, and older age were the 3 most important risk factors associated with worse outcomes. The subgroup analysis for the 3 most important risk factors revealed that patients without these risk factors had much better outcomes compared to those with all 3 risk factors (90% vs. 47% 1-year survival rate without repeat MV). Overall, elderly ARF survivors exhibited poor long-term respiratory outcomes, influenced by multiple factors. These findings highlight the need for careful clinical assessment and further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.